gold-investing NevGold Extends Oxide Gold-Antimony Mineralization Over 1.7 Kilometers at Cadillac Valley Target: 2.28 g/t AuEq Over 30.5 Meters (1.29 g/t Au And 0.22% Antimony) Within 1.61 g/t AuEq Over 61.0 Meters (1.08 g/t Au And 0.12% Antimony)
gold-investing NevGold Discovers More Significant Oxide Gold-Antimony Results: 2.11 g/t AuEq Over 67.1 Meters (1.30 g/t Au And 0.18% Antimony), Including 4.29 g/t AuEq Over 30.5 Meters (2.79 g/t Au And 0.33% Antimony), and Also Including 7.12 g/t AuEq Over 16.8 Meters (5.05 g/t Au And 0.46% Antimony) at the Limousine Butte Project, Nevada
gold-investing NevGold Discovers Further Significant Gold-Antimony Results: 2.46 g/t AuEq Over 86.9 Meters (1.11 g/t Au And 0.30% Antimony), Including 5.75 g/t AuEq Over 12.8 Meters (1.83 g/t Au And 0.87% Antimony), and Also Including 6.77 g/t AuEq Over 6.7 Meters (2.29 g/t Au And +1% Antimony) at the Limousine Butte Project, Nevada
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
